Dublin, Jan. 06, 2025 (GLOBE NEWSWIRE) -- The "Heart Failure: 68-Market Analysis and Sales Forecast" report has been added to ResearchAndMarkets.com's offering.
This report covers the 68 geographical markets and provides an Excel-based forecast model for the Heart Failure (HF) market through 2032.
Across the 68 markets, sales in the heart failure market were $21.6 billion in 2022, growing to $65.7 billion in 2032.
The seven major markets (US, France, Germany, Italy, Spain, UK, and Japan) represent approximately 62.5% and 51.4% of 68-market sales in 2022 and 2032, respectively.
Report Scope
- This publication is an expanded version of the Excel model containing the patient-based forecast sales for heart failure (HF), covered in the report "Heart Failure: Seven -Market Drug Forecast and Market Analysis Update", published in November 2024.
- In addition to patient based forecast sales data for the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan), this report contains sales forecast extrapolations for an additional 60 geographical markets (60M), totaling 68 markets (68M).
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the 7MM HF therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the 7MM HF therapeutics market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Company Coverage:
- Amgen
- Bayer
- Zensun
- AstraZeneca
- Boehringer Ingelheim
- Lexicon
- CSL Vifor
- Eli Lilly
- Novartis
- Novo Nordisk
- Mesoblast
- BioCardia
- Eris LifeSciences
- Cytokinetics
For more information about this report visit https://www.researchandmarkets.com/r/1e3p4n
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
